This is a tipica lresult of having an Incapable CEO working in the company. Investment decisions are made to benefit thieves, rather than the return of shareholders' fund. The trial result Ann gave us an impression that the phase III trial would follow very soon. But now they tell us that a partner has to be found first taking another 18 months before the phase 3 trial can happen. We were also told that the patent protection time left for capendavir is only several years. Didn't anyone push Pc on how they would achieve a positive return for what has been spent on Vapendavir?
We now know that PC will be gone in less that 18months. So he tends to give all his prediction a time frame of 18months.
The result if the meeting is full of lies and excuses, IMO.
Just my thoughts.
- Forums
- ASX - By Stock
- BTA
- melbourne meeting
melbourne meeting, page-22
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online